-
Board Certification
American Board of SurgeryPatient Rating
4.9 /5( out of 149 reviews )The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.
The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient Comments
Patient comments are gathered from our patient experience survey and displayed in their entirety.
Patients are de-identified for confidentiality and patient privacy.September 04, 2024HUNTSMAN CANCER CENTERShe helped me feel better as I was very scared
July 29, 2024HUNTSMAN CANCER CENTERI would give Dr. Rosenthal a higher score than "very good" if I could. She has made me feel comfortable calm and well informed. I feel she gave me the best treatment possible. I have been well cared for.
July 24, 2024HUNTSMAN CANCER CENTERDr. Rosenthal is kind and caring. She takes time to carefully communicate and offer options, guidance, and respect for your feelings, choices, and decisions. She listens to you and welcomes your questions and concerns.
July 24, 2024HUNTSMAN CANCER CENTERSee previous note since it was all about her. She is top notch.
July 20, 2024HUNTSMAN CANCER CENTERDr. Rosenthal is amazing!!!
July 18, 2024HUNTSMAN CANCER CENTERDr. Rosenthal was very good to listen to my concerns in the direction my Cancer seems to be moving. She took time to explain things to me and we ran a few tests to get a better picture of my lump. Those tests will help us figure out which direction to go in my treatment.
July 18, 2024HUNTSMAN CANCER CENTERVery attentive.
July 17, 2024HUNTSMAN CANCER CENTERDr Rosenthal is incredible: intelligent, caring, professional.
July 10, 2024HUNTSMAN CANCER CENTERDr. Rosenthal is an amazing doctor that doesn't talk medical jargon but explains everything in a way that I understood.
-
Board Certification and Academic Information
Academic Departments Surgery -Primary Academic Divisions Surgical Oncology
Board Certification American Board of SurgeryEducation history
Research Fellow Oncology - Boston University Medical Center Research Fellow Boston University Administrative Chief Resident Residency Boston University Resident Boston University Intern Professional Medical Medicine - Albert Einstein College of Medicine M.D. Biochemistry - City College of New York B.S. Selected Publications
Journal Article
- Vaklavas C, Matsen CB, Chu Z, Boucher KM, Scherer SD, Pathi S, Beck A, Brownson KE, Buys SS, Chittoria N, DAstous E, Gulbahce HE, Henry NL, Kimani S, Porretta J, Rosenthal R, Ward J, Wei M, Welm BE, Welm AL (2024). TOWARDS Study: Patient-Derived Xenograft Engraftment Predicts Poor Survival in Patients With Newly Diagnosed Triple-Negative Breast Cancer. JCO Precis Oncol, 8, e2300724. (Read full article)
- Covington MF, Hoffman JM, Morton KA, Buckway B, Boucher KM, Rosenthal R, Porretta J, Brownson KE, Matsen CB, Vaklavas C, Ward JH, Wei M, Buys SS, Chittoria N, Yakish ED, Archibald ZG, Burrell LD, Butterfield RI, Yap JT (2023). Prospective Pilot Study of (18)F-Fluoroestradiol PET/CT in Patients With Invasive Lobular Carcinomas. AJR Am J Roentgenol, 221(2), 228-239. (Read full article)
- Erickson JR, Pahlkotter MK, Thielking PD, Porretta JM, Rosenthal R, Matsen CB, Brownson KE (2023). Leveraging telehealth supportive oncology services to combat COVID-19 isolation in breast cancer patients: A cancer center’s perspective. Patient Exp J, 10(2), 133-137.
- Erickson JR, Pahlkotter MK, Thielking PD, Porretta JM, Rosenthal R, Matsen CB, Brownson KE (2023). Leveraging telehealth supportive oncology services to combat COVID-19 isolation in breast cancer patients: A cancer center’s perspective. Patient Exp J, 10(2), 133-137. (Read full article)
- Guillen KP, Fujita M, Butterfield AJ, Scherer SD, Bailey MH, Chu Z, DeRose YS, Zhao L, Cortes-Sanchez E, Yang CH, Toner J, Wang G, Qiao Y, Huang X, Greenland JA, Vahrenkamp JM, Lum DH, Factor RE, Nelson EW, Matsen CB, Poretta JM, Rosenthal R, Beck AC, Buys SS, Vaklavas C, Ward JH, Jensen RL, Jones KB, Li Z, Oesterreich S, Dobrolecki LE, Pathi SS, Woo XY, Berrett KC, Wadsworth ME, Chuang JH, Lewis MT, Marth GT, Gertz J, Varley KE, Welm BE, Welm AL (2022). A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology. Nat Cancer, 3(2), 232-250. (Read full article)
-
News & Podcasts
Huntsman Cancer Institute News